Skip to contents
In This Issue:
Tuesday marked the launch of the Ann Romney Center for Neurologic Diseases at BWH, a global collaboration to confront five of the world’s most complex and devastating neurologic diseases.
Building upon BWH’s legacy of life-giving breakthroughs in neurologic disease, the Ann Romney Center for Neurologic Diseases will accelerate treatment, prevention and the search for cures for Multiple Sclerosis (MS), Alzheimer’s disease, ALS (also known as Lou Gehrig’s disease), Parkinson’s disease and brain tumors.
“When future generations look back on this date, they will note that this was an important moment in history not only for Brigham and Women’s Hospital, but more importantly, for those 50 million people afflicted with devastating neurologic diseases,” said BWH President Betsy Nabel, MD, at an event celebrating the center’s unveiling at the Wang Theatre. “Tonight, we are transforming the future of medicine.”
Romney and her family have been a driving force in the center’s creation. Romney, who waged her own battle with MS, will serve as a champion of the center’s mission.
“Tonight is a moment of joy,” said Romney at the event. “We are going to provide hope to those suffering from neurologic diseases. We have the right people, the right building, the right science and the right accelerant to make a real difference.”
Below the elegant gold and red decor of the historic Wang Theatre, BWH leaders and neurology experts, government representatives, friends and family of the Romneys and others learned more about the new center, which will be housed in the Brigham Building for the Future when it opens in 2016. The center will use novel forms of collaboration and patient-centered research, both within the walls of BWH and beyond, to discover innovations and new treatments across teams, labs and institutions.
Under the exemplary leadership of BWH’s Howard Weiner, MD, and Dennis Selkoe, MD, the center will bring together some of the world’s brightest scientific and medical minds to develop treatments and search for cures.
During the past 30 years, Weiner and Selkoe have harnessed the power of collaboration to drive innovation in neurologic disease, and their teams have an unparalleled track record of firsts in neurologic disease discoveries.
Learn more about the new center at